These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8204254)

  • 1. [Response to combined therapy with plasmapheresis and high doses of immunoglobulin in Lambert-Eaton syndrome].
    Díez-Tejedor E; Tejada J; Ramos MJ; Frank A; Cruz-Martínez A; Vivancos F; Barreiro P
    Neurologia; 1994 Feb; 9(2):76-7. PubMed ID: 8204254
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome with small-cell lung cancer: correlation with the titer of anti-voltage-gated calcium channel antibody.
    Takano H; Tanaka M; Koike R; Nagai H; Arakawa M; Tsuji S
    Muscle Nerve; 1994 Sep; 17(9):1073-5. PubMed ID: 8065398
    [No Abstract]   [Full Text] [Related]  

  • 3. "Dropped head syndrome" caused by Lambert-Eaton myasthenic syndrome.
    Ueda T; Kanda F; Kobessho H; Hamaguchi H; Motomura M
    Muscle Nerve; 2009 Jul; 40(1):134-6. PubMed ID: 19533655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic approaches to Lambert-Eaton myasthenic syndrome in the intra-individual comparison.
    Jost WH; Mielke U; Schimrigk K
    Wien Klin Wochenschr; 1991; 103(20):629-32. PubMed ID: 1763511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome.
    Peterlin BL; Flood W; Kothari MJ
    J Am Osteopath Assoc; 2002 Dec; 102(12):682-4. PubMed ID: 12501987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Semin Neurol; 2003 Jun; 23(2):191-8. PubMed ID: 12894384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lambert-Eaton myasthenic syndrome: evaluation of movement performance following drug therapy.
    Cooke JD; Hefter H; Brown SH; Toyka KV; Freund HJ
    Electromyogr Clin Neurophysiol; 1994 Mar; 34(2):87-93. PubMed ID: 8187683
    [No Abstract]   [Full Text] [Related]  

  • 8. Available treatment options for the management of Lambert-Eaton myasthenic syndrome.
    Verschuuren JJ; Wirtz PW; Titulaer MJ; Willems LN; van Gerven J
    Expert Opin Pharmacother; 2006 Jul; 7(10):1323-36. PubMed ID: 16805718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A diagnostic and management dilemma: combined paraneoplastic myasthenia gravis and Lambert-Eaton myasthenic syndrome presenting as acute respiratory failure.
    Roohi F; Smith PR; Bergman M; Baig MA; Sclar G
    Neurologist; 2006 Nov; 12(6):322-6. PubMed ID: 17122730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lambert-Eaton myasthenic syndrome: response to treatment with 3,4-diaminopyridine].
    Morata C; Alfaro A; Chumillas MJ; Montalar J
    Med Clin (Barc); 1995 Feb; 104(4):156. PubMed ID: 7898163
    [No Abstract]   [Full Text] [Related]  

  • 11. Myasthenia gravis and myasthenic syndrome.
    Antozzi C
    Neurol Sci; 2003 Oct; 24 Suppl 4():S260-3. PubMed ID: 14598056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
    Lorenzoni PJ; Scola RH; Lang B; Kay CS; Teive HA; Kowacs PA; Werneck LC
    J Neurol Sci; 2008 Jul; 270(1-2):194-6. PubMed ID: 18374949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of systemic lupus erythematosus and Lambert-Eaton myasthenic syndrome.
    Deodhar A; Norden J; So Y; Bennett R
    J Rheumatol; 1996 Jul; 23(7):1292-4. PubMed ID: 8823710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of anti P/Q type VGCC antibody positive small lung cell carcinoma that occured with subacute cerebellar degeneration, Lambert-Eaton myasthenic syndrome, and brainstem encephalitis].
    Nagayama S; Koike F; Sakai T; Antoku Y; Yukitake M; Kuroda Y
    Brain Nerve; 2008 Dec; 60(12):1470-4. PubMed ID: 19110759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable response to rituximab in a patient with anti-VGCC-positive Lambert-Eaton myasthenic syndrome and cerebellar dysfunction.
    Pellkofer HL; Voltz R; Kuempfel T
    Muscle Nerve; 2009 Aug; 40(2):305-8. PubMed ID: 19609921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eaton-Lambert syndrome: an early and initial presentation in a case of bronchogenic carcinoma.
    Biswas TK; Das AK; Pandey GC; Roy DN
    J Indian Med Assoc; 1990 Mar; 88(3):88, 90. PubMed ID: 2262692
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of the paraneoplastic Lambert-Eaton syndrome].
    Courau E; Westeel V; Jacoulet P; Depierre A
    Rev Pneumol Clin; 1998 May; 54(2):65-70. PubMed ID: 9769989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lambert-eaton myasthenic syndrome: a case report and review of the literature.
    Lin JT; Lachmann E
    J Womens Health (Larchmt); 2002 Dec; 11(10):849-55. PubMed ID: 12626085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study.
    Wirtz PW; Verschuuren JJ; van Dijk JG; de Kam ML; Schoemaker RC; van Hasselt JG; Titulaer MJ; Tjaden UR; den Hartigh J; van Gerven JM
    Clin Pharmacol Ther; 2009 Jul; 86(1):44-8. PubMed ID: 19357643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.